Cingulate Inc (CING): Next-Year EPS Estimate 45.15%

As of 2026-06-04, Cingulate Inc (CING) has a next-year EPS growth estimate of 45.15%.

Detected 2026-05-26
First flagged by our EPS-revision screen

CING was first flagged by our screen on 2026-05-26 with a next-year EPS growth estimate of 45.15%. Current-year growth is projected at 45.87%.

Current Snapshot

Sector
Healthcare
Industry
Biotechnology
EPS growth next year
45.15%
EPS growth this year
45.87%
EPS next quarter (est)
-$0.64
Last price
$4.80

EPS Revision History

56.8%26.2%03-1706-04
Next-year EPS growth estimate · 24 observations
92.0%90.0%05-2606-04
Combined EPS growth (this year + next year) · 8 observations
DateEPS Next YEPS This YNext Q (est)Price
2026-06-0445.15%45.87%-$0.64$4.80
2026-06-0345.15%45.87%-$0.64$4.88
2026-06-0245.15%45.87%-$0.64$4.03
2026-06-0145.15%45.87%-$0.64$3.60
2026-05-3145.15%45.87%-$0.64$4.16
2026-05-2845.15%45.87%-$0.64$4.34
2026-05-2745.15%45.87%-$0.64$3.96
2026-05-2645.15%45.87%-$0.64$4.78
2026-04-0726.17%N/A-$0.57$5.94
2026-04-0626.17%N/A-$0.57$5.94
2026-04-0537.70%N/A-$0.48$6.14
2026-04-0326.17%N/A-$0.57$5.94
2026-04-0226.17%N/A-$0.57$5.94
2026-04-0126.17%N/A-$0.57$5.94
2026-04-0137.70%N/AN/A$6.01
2026-04-0137.70%N/AN/A$6.01
2026-04-0137.70%N/AN/A$6.01
2026-03-3137.70%N/AN/A$6.21
2026-03-3137.70%N/AN/A$6.21
2026-03-3137.70%N/AN/A$6.21
2026-03-3037.70%N/AN/A$5.84
2026-03-3037.70%N/AN/A$5.84
2026-03-3037.70%N/AN/A$5.84
2026-03-2937.70%N/AN/A$6.39
2026-03-2937.70%N/AN/A$6.39
2026-03-2737.70%N/AN/A$6.39
2026-03-2637.70%N/AN/A$6.28
2026-03-2637.70%N/AN/A$6.28
2026-03-2637.70%N/AN/A$6.28
2026-03-2537.70%N/AN/A$6.36

Screen Performance

Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.

Median return since detection
+5.1%
% of tickers in the green
62%
Median return on winners
+17.5%
Large revisions captured
746

Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.

Frequently Asked Questions

What is Cingulate Inc's next-year EPS growth estimate?

As of 2026-06-04, Cingulate Inc (CING) has a next-year EPS growth estimate of 45.15%, based on analyst consensus.

When was the latest EPS estimate revision for CING?

The most recent revision occurred on 2026-05-26, when analysts adjusted the next-year EPS growth estimate from 26.17% to 45.15%.

What sector and industry does Cingulate Inc belong to?

Cingulate Inc operates in the Healthcare sector, specifically the Biotechnology industry.

How often is this EPS estimate data updated?

EPS revision data is refreshed daily from analyst consensus estimates. CING appears on this page because it was flagged by our daily top-EPS-revision-performer screen.

EPS revision data sourced from analyst consensus estimates, refreshed daily. Cingulate Inc (CING) appears here because it was detected by our daily top-EPS-revision-performer screen.

← All reports